Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimagrumab in prolonged mechanical ventilation
NCT01868685Phase 2Withdrawn
- Sponsor
- Novartis
- Start
- Apr 2014
- Primary completion
- Jan 2015
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of bimagrumab in Weaning failure, muscle atrophy, sponsored by Novartis. Planned start Apr 2014; status: withdrawn.
02
Drugs
bimagrumab
03
Conditions
Weaning failuremuscle atrophy
Beyond the preview
Go deeper on NCT01868685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01868685.